Ursodeoxycholic acid

10mM in DMSO

Reagent Code: #244982
fingerprint
CAS Number 128-13-2

science Other reagents with same CAS 128-13-2

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 392.57 g/mol
Formula C₂₄H₄₀O₄
badge Registry Numbers
EC Number 204-879-3
MDL Number MFCD00003680
thermostat Physical Properties
Melting Point 203-204 °C(lit.)
inventory_2 Storage & Handling
Storage -20°C

description Product Description

Used primarily in the treatment of gallstones, especially in patients who cannot undergo surgery. It helps dissolve cholesterol-rich gallstones by reducing cholesterol secretion into bile and promoting bile flow. Also widely prescribed for primary biliary cholangitis (PBC), where it improves liver function tests and may delay disease progression. Commonly used in managing cholestatic liver diseases in children and adults, including intrahepatic cholestasis of pregnancy, to reduce itching and improve liver parameters. Investigated for non-alcoholic fatty liver disease (NAFLD) due to its protective effects on liver cells. Used in some countries to treat cystic fibrosis-related liver disease. Its mechanism includes stabilizing cell membranes, reducing apoptosis, and exerting anti-inflammatory effects in the liver.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 1ml
10-20 days ฿1,290.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Ursodeoxycholic acid
No image available
Used primarily in the treatment of gallstones, especially in patients who cannot undergo surgery. It helps dissolve cholesterol-rich gallstones by reducing cholesterol secretion into bile and promoting bile flow. Also widely prescribed for primary biliary cholangitis (PBC), where it improves liver function tests and may delay disease progression. Commonly used in managing cholestatic liver diseases in children and adults, including intrahepatic cholestasis of pregnancy, to reduce itching and improve liver parameters. Investigated for non-alcoholic fatty liver disease (NAFLD) due to its protective effects on liver cells. Used in some countries to treat cystic fibrosis-related liver disease. Its mechanism includes stabilizing cell membranes, reducing apoptosis, and exerting anti-inflammatory effects in the liver.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...